​

Prelude Therapeutics (PRLD) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Prelude Therapeutics Revenue Highlights

Latest Revenue (Y)

$12.14M

Latest Revenue (Q)

$5.70M

Prelude Therapeutics Revenue by Period

Prelude Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$12.14M73.43%
2024-12-31$7.00M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Prelude Therapeutics generated $12.14M in revenue during NA 2025, up 73.43% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Prelude Therapeutics Revenue by Quarter

DateRevenueChange
2026-06-30$5.70M24.54%
2026-03-31$4.58M-18.79%
2025-12-31$5.64M-13.23%
2025-09-30$6.50M100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$4.00M33.33%
2024-09-30$3.00M100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Prelude Therapeutics generated $5.70M in revenue during Q2 2026, up 24.54% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Prelude Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ENTAEnanta Pharmaceuticals$65.32M$14.36M
OBIOOrchestra BioMed$33.48M$88.00K
FHTXFoghorn Therapeutics$30.91M$16.07M
IVAInventiva$17.48M$2.73M
PYXSPyxis Oncology$13.86M-
PRLDPrelude Therapeutics$12.14M$5.70M
AVTXAvalo Therapeutics$59.00K-
IMRXImmuneering-$360.96K
EPRXEupraxia Pharmaceuticals--
CRBUCaribou Biosciences--
TNYATenaya Therapeutics-$1.11M

PRLD Revenue FAQ

What is Prelude Therapeutics’s yearly revenue?

Prelude Therapeutics's yearly revenue for 2025 was $12.14M, representing an increase of 73.43% compared to 2024. The company's yearly revenue for 2024 was $7M, representing an increase of 100.00% compared to 2023. PRLD's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Prelude Therapeutics’s quarterly revenue?

Prelude Therapeutics's quarterly revenue for Q2 2026 was $5.7M, a 24.54% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $4.58M, a -18.79% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). PRLD's quarterly revenue for Q4 2025 was $5.64M, a -13.23% decrease from the previous quarter (Q3 2025), and a 41.00% increase year-over-year (Q4 2024).

What is Prelude Therapeutics’s revenue growth rate?

Prelude Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.